Search results
Here's What is Driving Amgen (AMGN) Stock's Outperformance
Zacks via Yahoo Finance· 1 year agoAmgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the...
20 Countries with Lowest Rates of Cancer
Insider Monkey via Yahoo Finance· 7 months agoIn this article, we will be taking a look at the 20 countries with lowest rates of cancer. If you want to skip our analysis of the oncology industry,...
2 Best Biotech Stocks to Buy Right Now
Motley Fool· 2 years agoThe launch of quality healthcare services and products over the past several decades has had an overwhelmingly positive impact on society. That's because...
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Oncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag
Zacks via Yahoo Finance· 1 year agoOncolytics Biotech (ONCY) receives a fast-track designation from the FDA for pelareorep combined...
The Amgen Inc (AMGN) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoAmgen Inc (NASDAQ:AMGN) continues to lead in biotechnology-based human therapeutics, with a strong portfolio of flagship drugs. The company's recent...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 8 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...
Amgen (AMGN) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to...
How Triple-Refractory Multiple Myeloma Is Treated
Verywell Health via Yahoo News· 2 years agoTriple refractory multiple myeloma usually requires the use of two or more different kinds of drugs to improve survival outcomes and quality of life....
Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 10 months agoAmgen AMGN reported second-quarter 2023 earnings of $5.00 per share, which beat the Zacks Consensus...
